JP2009530304A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530304A5
JP2009530304A5 JP2009500521A JP2009500521A JP2009530304A5 JP 2009530304 A5 JP2009530304 A5 JP 2009530304A5 JP 2009500521 A JP2009500521 A JP 2009500521A JP 2009500521 A JP2009500521 A JP 2009500521A JP 2009530304 A5 JP2009530304 A5 JP 2009530304A5
Authority
JP
Japan
Prior art keywords
oxo
isoquinolin
dihydro
hydroxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009500521A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530304A (ja
JP5240941B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/006735 external-priority patent/WO2007109192A2/en
Publication of JP2009530304A publication Critical patent/JP2009530304A/ja
Publication of JP2009530304A5 publication Critical patent/JP2009530304A5/ja
Application granted granted Critical
Publication of JP5240941B2 publication Critical patent/JP5240941B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009500521A 2006-03-16 2007-03-16 P2x7調節因子としてのビシクロへテロアリール化合物およびその使用 Active JP5240941B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US78359006P 2006-03-16 2006-03-16
US78292306P 2006-03-16 2006-03-16
US78312106P 2006-03-16 2006-03-16
US60/783,121 2006-03-16
US60/783,590 2006-03-16
US83141606P 2006-07-17 2006-07-17
US60/831,416 2006-07-17
US90604907P 2007-03-09 2007-03-09
US60/906,049 2007-03-09
PCT/US2007/006735 WO2007109192A2 (en) 2006-03-16 2007-03-16 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
US60/782,923 2007-03-16

Publications (3)

Publication Number Publication Date
JP2009530304A JP2009530304A (ja) 2009-08-27
JP2009530304A5 true JP2009530304A5 (enExample) 2010-04-08
JP5240941B2 JP5240941B2 (ja) 2013-07-17

Family

ID=38523012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009500521A Active JP5240941B2 (ja) 2006-03-16 2007-03-16 P2x7調節因子としてのビシクロへテロアリール化合物およびその使用

Country Status (12)

Country Link
US (2) US7816371B2 (enExample)
EP (1) EP1933622B1 (enExample)
JP (1) JP5240941B2 (enExample)
CN (1) CN101442909B (enExample)
AR (1) AR059920A1 (enExample)
BR (1) BRPI0709581A8 (enExample)
CA (1) CA2645568C (enExample)
DK (1) DK1933622T3 (enExample)
ES (1) ES2569352T3 (enExample)
MX (1) MX2008011922A (enExample)
TW (1) TWI464148B (enExample)
WO (1) WO2007109192A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2124562T3 (en) * 2007-03-09 2016-08-01 Second Genome Inc BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof
CA2699631A1 (en) 2007-10-31 2009-05-07 Nissan Chemical Industries, Ltd. Pyridazinone compounds and p2x7 receptor inhibitors
EP2105164B1 (en) 2008-03-25 2011-01-12 Affectis Pharmaceuticals AG Novel P2X7R antagonists and their use
WO2010019210A2 (en) * 2008-08-11 2010-02-18 President And Fellows Of Harvard College Halofuginone analogs for inhibition of trna synthetases and uses thereof
GB0906274D0 (en) 2009-04-09 2009-05-20 Ge Healthcare Ltd Imaging the central nervous system
ATE541832T1 (de) 2009-04-14 2012-02-15 Affectis Pharmaceuticals Ag Neuartige p2x7r-antagonisten und ihre verwendung
EP2386541A1 (en) 2010-05-14 2011-11-16 Affectis Pharmaceuticals AG Novel methods for the preparation of P2X7R antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
MX2014000894A (es) 2011-07-22 2014-02-27 Actelion Pharmaceuticals Ltd Derivados de amidas heterociclicas como antagonistas de receptores p2x7.
JP2015506363A (ja) 2012-01-13 2015-03-02 プレジデント アンド フェローズ オブ ハーバード カレッジ ハロフジノール誘導体、および化粧料組成物および医薬組成物におけるその使用
BR112014017735B1 (pt) 2012-01-20 2022-06-28 Idorsia Pharmaceuticals Ltd Compostos derivados de amida heterocíclicos como antagonistas do receptor de p2x7, composição farmacêutica, e, uso de um composto
EP2931717B1 (en) 2012-12-12 2016-12-07 Actelion Pharmaceuticals Ltd. Indole carboxamide derivatives as p2x7 receptor antagonists
CA2891499C (en) 2012-12-18 2021-07-06 Actelion Pharmaceuticals Ltd Indole carboxamide derivatives as p2x7 receptor antagonists
CN104918617B (zh) 2013-01-22 2017-05-10 埃科特莱茵药品有限公司 作为p2x7受体拮抗剂的杂环酰胺衍生物
JP6282017B2 (ja) 2013-01-22 2018-02-21 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd P2x7受容体アンタゴニストとしての複素環アミド誘導体
NZ724691A (en) * 2014-03-24 2018-02-23 Guangdong Zhongsheng Pharmaceutical Co Ltd Quinoline derivatives as smo inhibitors
BR112016023991A2 (pt) * 2014-04-17 2017-08-15 Novartis Ag ativadores de herg policíclicos
CN105596301A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法
WO2019099509A1 (en) * 2017-11-14 2019-05-23 Second Genome, Inc. Use of a p2x7 receptor antagonist to treat an inflammatory disease or disorder
WO2019237125A1 (en) 2018-06-08 2019-12-12 The General Hospital Corporation Inhibitors of prolyl-trna-synthetase
RS67100B1 (sr) 2020-03-31 2025-09-30 Remicine Ip B V Lečenje hiperinflamatornog sindroma
EP4247376A4 (en) * 2020-11-20 2024-11-27 Denali Therapeutics Inc. COMPOUNDS, COMPOSITIONS AND METHODS
TWI825637B (zh) 2021-03-31 2023-12-11 美商輝瑞股份有限公司 啶-1,6(2h,7h)-二酮
WO2022232632A1 (en) * 2021-04-30 2022-11-03 Denali Therapeutics Inc. Compounds, compositions, and methods
GB2607584B (en) * 2021-06-03 2024-07-17 Stichting Medische Kliniek Velsen Composition and method of treatment

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2640829A (en) 1950-11-10 1953-06-02 Smith Kline French Lab Isoquinolyl heterocyclic ethers
US3978066A (en) 1973-11-06 1976-08-31 Ayerst, Mckenna And Harrison Ltd. Certain 4,6-dihydropyrrolotriazoline-quinoline derivatives
KR920008026A (ko) 1990-10-24 1992-05-27 오노 화아마슈티칼 캄파니 리미팃드 이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
CA2307030A1 (en) * 1997-10-24 1999-05-06 Mervyn Thompson Substituted isoquinoline derivatives and their use as anticonvulsants
SE9704544D0 (sv) 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
SE9704546D0 (sv) 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
SE9704545D0 (sv) 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
US6380193B1 (en) 1998-05-15 2002-04-30 Guilford Pharmaceuticals Inc. Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
PL210415B1 (pl) 1999-01-11 2012-01-31 Agouron Pharma Pochodne indolu, środek farmaceutyczny i zastosowanie pochodnych indolu
SE9901875D0 (sv) 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
PL359340A1 (en) 2000-05-19 2004-08-23 Triazole derivatives
WO2002094790A1 (en) 2001-05-23 2002-11-28 Mitsubishi Pharma Corporation Fused heterocyclic compound and medicinal use thereof
CA2455181C (en) 2001-08-01 2010-04-06 Merck & Co., Inc. Benzimidazo[4,5-f]isoquinolinone derivatives
GB0206876D0 (en) 2002-03-22 2002-05-01 Merck Sharp & Dohme Therapeutic agents
SE0200920D0 (sv) * 2002-03-25 2002-03-25 Astrazeneca Ab Novel compounds
DE10215316C1 (de) 2002-04-02 2003-12-18 Schering Ag Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
RS95404A (sr) 2002-05-03 2006-10-27 Schering Aktiengesellschaft Tiazolidinoni i njihova primena kao inhibitora polo like kinaze
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
AU2003301443A1 (en) 2002-10-18 2004-05-04 E.I. Du Pont De Nemours And Company Azolecarboxamide herbicides
KR100751604B1 (ko) 2003-03-03 2007-08-22 에프. 호프만-라 로슈 아게 5-ht6 조절자로서 사용되는 2,5- 및 2,6-치환된테트라하이드로아이소퀴놀린
WO2004106324A1 (en) * 2003-05-27 2004-12-09 E.I. Dupont De Nemours And Company Azolecarboxamide herbicides
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
CN1566099A (zh) 2003-06-13 2005-01-19 中国科学院上海药物研究所 异喹啉-1,3,4-三酮类化合物、制备方法及其用途
DE502004002403D1 (de) 2003-10-08 2007-02-01 Schering Ag Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
US7491794B2 (en) * 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
US7312330B2 (en) 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
TW200530235A (en) 2003-12-24 2005-09-16 Renovis Inc Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
SE0400284D0 (sv) 2004-02-10 2004-02-10 Astrazeneca Ab Novel compounds
WO2005105814A1 (en) 2004-04-28 2005-11-10 Incyte Corporation Tetracyclic inhibitors of janus kinases
US20050267202A1 (en) 2004-05-19 2005-12-01 Konrad Krolikiewicz Chromanol derivatives, a process for their production and their use as anti-inflammatory agents
DE102004055633A1 (de) 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
JPWO2006057270A1 (ja) 2004-11-26 2008-06-05 旭化成ファーマ株式会社 含窒素3環化合物
DE102004063227A1 (de) 2004-12-22 2006-07-06 Schering Ag Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US7297700B2 (en) * 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
DK2124562T3 (en) * 2007-03-09 2016-08-01 Second Genome Inc BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof

Similar Documents

Publication Publication Date Title
JP2009530304A5 (enExample)
JP2008534511A5 (enExample)
JP2010520875A5 (enExample)
JP2009530302A5 (enExample)
JP2009541206A5 (enExample)
JP2008537741A5 (enExample)
JP5240941B2 (ja) P2x7調節因子としてのビシクロへテロアリール化合物およびその使用
JP6337109B2 (ja) ナトリウムチャネルの調節剤としてのスルホンアミド
JP5349332B2 (ja) 新規化合物、その調製方法、およびその使用
ES2398606T3 (es) Derivados de 2-piridin-carboxamida como moduladores de los canales de sodio
CA2693588C (en) Sodium channel inhibitors
JP2012509332A5 (enExample)
JP2016506387A5 (enExample)
JP4036343B2 (ja) 疾患の治療のためのスルフォンアミド誘導体
JP4762903B2 (ja) 新規のベンゾイミダゾール誘導体
ES2293530T3 (es) Derivados de sulfonamidas para el tratamiento de enfermedades.
RU2006105639A (ru) Новые производные аминобензофенона
CA2710409A1 (en) 6h-dibenz0 [b,e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists
RU2015105521A (ru) Гетероциклические молдуляторы активности hif для лечения заболеваний
WO2009112445A1 (en) Method of increasing cellular phosphatidyl choline by dgat1 inhibition
JP2010524930A5 (enExample)
HRP20110809T1 (hr) Protuupalni pirimidini i njihove uporabe
WO2011022348A1 (en) Ethylene diamine modulators of fatty acid amide hydrolase
JP2014525425A5 (enExample)
ES2308562T3 (es) Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos.